HEMACORE

HemaCore was founded in 2010 as a biotech company focused on developing, manufacturing and implementing into clinical practice new in vitro diagnostic technology for hemostasis - thrombodynamics. Thrombodynamics assay – an innovative coagulation test for risk assessment of blood coagulation disorders – bleedings and thrombosis. Value proposition: they help clinicians succeed, providing clear and reliable estimation of patients coagulation state, thus giving an ability to prevent thrombotic or bleeding complications.